NEW YORK, April 21, 2016 /PRNewswire/ -- Vaccination is the process of imitating naturally acquired immunity through insertion of immunological components of pathogens. The term Vaccine was coined by Edward Jenner while working on the treatment of small pox in humans. The parameters for successful animal vaccine are different depending upon the animal groups. Vaccines have played a crucial role in elimination of host of diseases in animals such as classical swine fever and parvovirosis. But there are issues surrounding the use of vaccines such as safety, government regulations and the prevalence of disease in specific environment. The use of Veterinary Vaccines has immense potential to propel towards high growth.
The Veterinary Vaccines market is segregated on the basis of type of vaccines; Veterinary Viral Vaccines, Veterinary Bacterial Vaccines, Veterinary Parasite Vaccines and Veterinary Vaccines for Infectious Diseases. These are further segmented based on the type of pathogen such as Viral Vaccines, DNA Vaccines, Gene-Deleted Vaccines, Protozoal Vaccines and Cancer Vaccines. The Veterinary Vaccines market is also differentiated on the type of diseases. The vaccines are formulated individually for different animal subsets such as Bovine Vaccines, Porcine Vaccines, Feline Vaccines, Canine Vaccines, Poultry Vaccines and Equine Vaccines. The vaccines can be used to eradicate the disease, like rinderpest virus. However, the triumph of an experimental vaccine lies in its successful commercialization. The commercialization aspect depends upon external factors such as global perspective for specific disease, commercial vitality and extensive research.
Major players in the Veterinary Vaccines market are profiled with company overview, financial overview, business strategies, product portfolios, recent developments and market shares of the key players.
Some prominent players profiled are:
Merck Animal Health
Ceva Animal Health
The Veterinary Vaccines account for only 23% of the overall animal health products market, but the market for Veterinary Vaccines is growing significantly due to technological advances and new diseases coming to light. The regulatory scenario associated with pre-clinical trials in veterinary vaccines is less stringent as compared to human vaccines. This reduces the market launch time period and research & development process. However, there are strict rules in Europe and US over the use of veterinary vaccines. The European Union has restricted the use of coccidiostats as poultry vaccine. The use of antibiotics is under scrutiny for development of veterinary vaccines. In U.S. the vaccine for non-infectious diseases falls under the jurisdiction of FDA which makes the regulatory scenario tough. However, other animal vaccines are registered under USDA which is relatively easier route. The Veterinary International Committee for Harmonization provides guidelines for European Union, Japan and US. The objective of the committee is to create technical benchmark for registration of veterinary vaccines.
The report also contains detailed and in-depth analysis of the segmentation of the Veterinary Vaccines market with respect to geographic regions The regions contained in the report have been segmented into Americas, Europe, Asia-Pacific (APAC) and Rest of the World (RoW). These regions are further categorized into eminent countries from the perspective of Veterinary Vaccines market.
Read the full report: http://www.reportlinker.com/p03759149-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/veterinary-vaccines-market-by-type-veterinary-viral-vaccines-veterinary-bacterial-vaccines-veterinary-parasite-vaccines-others-type-of-disease-bovine-vaccines-feline-vaccines-canine-vaccines-poultry-vaccines-equine-vacc-300255616.html